Pacira BioSciences, Inc. (PCRX) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $24.69 (+0.86%), Market cap $1.01B, P/E ratio 146.44, 52-week low–high $19.16 ~ $27.22.
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also dev
Financial statements, price targets, institutional (13F) holdings and related news for Pacira BioSciences, Inc. are updated in real time on BlackAll Trade.
Pacira BioSciences, Inc. trades at $24.69 (+0.86%). Real-time quotes and charts are available on BlackAll Trade.
Pacira BioSciences, Inc. has a market cap of about $1.01B. Its P/E ratio is 146.44.
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the U